Reseacher at Institut de Recherche en Sciences de la Sante, Burkina Faso
Bonewendé Mohamed BELEMLILGA is a distinguished Burkinabè research associate specializing in Animal Pharmacology and Physiology at the Institut de Recherche en Sciences de la Santé (IRSS/CNRST). With a career marked by extensive contributions to ethnopharmacology, phytomedicine development, and preclinical drug evaluation, he has become a central figure in advancing traditional medicine through scientific validation in Burkina Faso and across West Africa. His leadership extends to key roles such as Head of the Research and Evaluation Department at IRSS and editorial board member for the Science de la Santé journal. He is also actively involved in national research strategy formulation, having served on committees crafting the CNRST’s 2025–2029 strategic research plan. Dr. BELEMLILGA’s expertise is further reflected in over 50 peer-reviewed publications focusing on pharmacological studies, toxicity assessments, and the pharmacodynamic properties of medicinal plants. His dedication to bridging traditional knowledge and modern science has led him to coordinate and participate in several national and international research projects, educational programs, and clinical investigations. With a solid background in both experimental research and academic supervision, he represents a dynamic blend of scholarly depth, technical skill, and visionary research leadership in African health science innovation.
Professional Profile
Education
Dr. Bonewendé Mohamed BELEMLILGA pursued his higher education at the University of Ouagadougou, where he demonstrated a consistent commitment to excellence in health and biological sciences. He obtained his Bachelor’s degree in Biological Sciences in 2007, followed by a Master’s degree in Biological Sciences with a specialization in Animal Biology and Physiology in 2008. He then advanced to complete a DEA (Diplôme d’Études Approfondies) in Applied Pharmacology and Toxicology from the UFR-SDS in 2011, achieving honors for his academic performance. His doctoral studies culminated in a Ph.D. in Applied Pharmaceutical Sciences, with a specialization in Applied Pharmacology, awarded by the Doctoral School of Health in 2019. His dissertation focused on the pharmacological and phytochemical properties of Saba senegalensis, a plant traditionally used to treat parasitic infections. This strong academic foundation equipped Dr. BELEMLILGA with the skills necessary for rigorous scientific research in pharmacology and ethnomedicine. In addition, his multilingual proficiency in French and English and his strong computer skills enhance his ability to operate effectively in both national and international academic settings. His academic path reflects a deep-seated dedication to public health through biomedical innovation.
Professional Experience
Dr. BELEMLILGA’s professional journey is marked by a rich tapestry of research, teaching, and leadership roles. Since 2020, he has served as a research associate in Animal Pharmacology-Physiology at IRSS/CNRST, while also heading the Research and Evaluation Department since January 2024. He has been instrumental in multiple strategic planning committees, including the Commission for Research and Innovation, the CNRST’s disciplinary board, and the drafting of national research strategies for 2025–2029. As a temporary lecturer at Université Saint Thomas d’Aquin, he has also been active in academic mentorship, supervising multiple master’s and doctoral theses. His expertise has been recognized internationally, exemplified by training certifications in Good Clinical Practice (ICH E6 R2), clinical research, and laboratory quality systems. Dr. BELEMLILGA has coordinated numerous clinical and pharmacological projects, notably on phytomedicines for gastrointestinal and respiratory illnesses. His fieldwork includes internships and collaborative research across France, Côte d’Ivoire, and Ghana. He is a founding member of the Société de Pharmacologie et Toxicologie du Burkina (SOPHATOX-B) and a contributor to numerous workshops and training programs. Through these roles, he has demonstrated an unwavering commitment to evidence-based health science rooted in traditional knowledge.
Research Interest
Dr. BELEMLILGA’s research interests lie at the dynamic intersection of ethnopharmacology, parasitology, toxicology, and pharmacognosy. His central scientific pursuit focuses on validating traditional medicinal practices by elucidating the pharmacological properties of plant-based therapies used in Burkina Faso and West Africa. With a special emphasis on parasitic diseases and gastrointestinal infections, he has conducted extensive in vitro and in vivo experiments to evaluate antipyretic, anti-inflammatory, analgesic, antioxidant, and anthelmintic activities of natural plant extracts. Plants like Saba senegalensis, Balanites aegyptiaca, and Gomphrena serrata are frequently featured in his studies. His research also involves toxicological screening to ensure the safety of phytomedicines intended for human or veterinary use. In recent years, Dr. BELEMLILGA has expanded his interest into clinical trial design, especially in the context of plant-based antimalarial and anti-parasitic formulations. He is also actively engaged in capacity building and promoting best practices in traditional medicine production and usage. His research aims to bridge the gap between indigenous healing systems and modern biomedicine, contributing to global health initiatives through culturally grounded scientific innovation.
Research Skills
Dr. BELEMLILGA has cultivated a robust set of interdisciplinary research skills that underpin his expertise in ethnopharmacology and biomedical sciences. His core competencies include phytochemical screening, bioassay-guided fractionation, pharmacodynamic and toxicological testing of natural extracts, and the standardization of phytomedicines. He is well-versed in both qualitative and quantitative experimental techniques, ranging from in vivo efficacy trials to molecular analytical methods such as chemical profiling via molecular networking. His hands-on experience includes high-level laboratory procedures, animal experimentation, and clinical trial coordination adhering to international GCP standards. Dr. BELEMLILGA is proficient in project management, having led and contributed to multiple funded research initiatives across Africa and Europe. He is also skilled in academic writing and peer-review processes, serving as an excellent reviewer for several scientific journals. As a scientific trainer and lecturer, he has transferred knowledge to students and health professionals through numerous workshops, including those hosted by the WHO-TDR and local universities. His ability to design, implement, and evaluate complex biomedical studies places him at the forefront of research promoting safe and effective traditional medicine integration.
Awards and Honors
Dr. BELEMLILGA’s contributions have been acknowledged through numerous awards, certifications, and prestigious appointments. In 2022 and 2023, he was recognized with the Certificate of Excellence for his role as a peer reviewer in leading scientific journals. His leadership in the IRSS/CNRST has earned him positions on key national committees, such as the Commission for Research and Innovation and the Editorial Board of Sciences et Technique. He has received multiple certifications from renowned organizations like WHO-TDR and the Global Health Network, reflecting international recognition of his expertise in clinical research and pharmacological evaluation. As a founding member of SOPHATOX-B and a certified trainer in ethnopharmacology, Dr. BELEMLILGA has significantly contributed to capacity-building initiatives across West Africa. His scientific publications have garnered citations and respect within the fields of traditional medicine and drug development. His work has not only influenced policy frameworks in Burkina Faso but has also enhanced the global visibility of African medicinal plant research. These accolades underscore his commitment to excellence, collaboration, and innovation in public health research and education.
Conclusion
Dr. Bonewendé Mohamed BELEMLILGA exemplifies a new generation of African researchers bridging traditional medicine with modern pharmacological science. With a career grounded in rigorous education and enriched by international collaborations, he continues to push the boundaries of phytomedicine research in West Africa. His work has had a tangible impact on both policy and practice, particularly in the validation and clinical assessment of indigenous medicinal formulations. As a research associate, academic mentor, strategic planner, and scientific communicator, he has made enduring contributions to the biomedical landscape in Burkina Faso and beyond. His dedication to interdisciplinary research, ethical scientific practice, and public health empowerment demonstrates a holistic vision for African health innovation. Through an impressive portfolio of publications, funded projects, and leadership roles, Dr. BELEMLILGA is shaping the future of pharmacological research rooted in cultural relevance and scientific integrity. His continued efforts promise to yield new therapies, foster research capacity, and inspire the next generation of scholars committed to sustainable, evidence-based healthcare solutions in Africa and globally.
Publications Top Notes
-
chemical analysis by molecular networking methods on extracts of saba senegalensis and its anthelmintic activity on caenorhabditis elegans
Authors: Mohamed B. Belemlilga, Hazrina Hazni, Aristide Traore, Indira Dennemont, Sébastien Pomel, Sandrine Cojean, Mehdi A. Beniddir, Sylvin Ouedraogo, Christian Bories, Philippe M. Loiseau
Year: 2025
-
evaluation of anti-inflammatory activities and acute toxicity of the leaves aqueous macerate of boscia senegalensis
Authors: Mohamed B. Belemlilga, Mathieu Nitiema, Aristide Traore, Eric Nanema, Souleymane Compaore, G. Geoffroy Ouedraogo, Sylvain Ilboudo, Lazare Belemnaba, Noufou Ouedraogo, Félix B. Kini
Year: 2025
-
toxicity assessment of a phytomedicine based on an almond extract from the fruit of balanites aegyptiaca intended for helminthiases care in burkina faso
Authors: G. G. Ouedraogo, M. B. Belemlilga, T. Kouguilima, G. D. Somda, S. Ilboudo, S. Ouedraogo, A. Traore, L. Belemnaba, F. B. Kini, S. Ouedraogo
Year: 2025
-
acute toxicity and anthelmintic effects of gomphrena serrata extracts on adult worms and eggs of haemonchus contortus
Authors: H. Ouedraogo, M. B. Belemlilga, A. Traore, G. A. L. Boly, F. Moyenga, G. G. Ouedraogo, S. Ilboudo, L. Belemnaba, S. Ouedraogo
Year: 2024
-
antibacterial, anti-inflammatory and antioxidant activities of an acazy herbal formula used in traditional medicine to treat respiratory infections
Authors: M. B. Belemlilga, B. Bayala, G. A. L. Boly, M. A. Ouédraogo, A. R. Boina, B. Yaro, F. Badea, C. Diguti, M. Koala, D. P. Ilboudo, et al.
Year: 2024
-
optimization and standardization of the extraction method of balanites aegyptiaca seeds used in the formulation of an antiparasitic phytomedicine
Authors: M. B. Belemlilga, S. Ouedraogo, G. A. L. Boly, D. H. Dao, J. T. Coulibaly, J. C. R. P. Ouedraogo, S. Compaoré, S. Traore, M. Koala, E. N. H. Youl
Year: 2024
-
evaluation of acute and subacute toxicity and sedative effect of feretia apodanthera leaves
Authors: A. S. Silue, S. Ilboudo, T. A. Djadji, G. Ouedraogo, M. B. Belemlilga, G. Kouakou-Siransy, R. Semdé
Year: 2024
-
phytochemical profile, acute toxicity, antioxidant and anti-inflammatory activity of hydroethanolic extracts from odontonema strictum root and stem
Authors: M. Nitiema, L. Belemnaba, C. W. R. Ouedraogo, M. B. Belemlilga, S. Ouedraogo, M. Koala, A. Traore, J. F. Aïkpe, N. Ouedraogo, F. B. Kini
Year: 2024
-
phytochemical and in vitro anthelmintic properties of mesocarp of fruit extracts from balanites aegyptiaca
Author: Mohamed Bonewendé Belemlilga
Year: 2024